Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

WEST COAST NUCLEAR PHARMACY, LLC

UEI: WFYSHK4214C8CAGE: 73XA9

WEST COAST NUCLEAR PHARMACY, LLC is a federal contractor, registered under UEI WFYSHK4214C8 and CAGE code 73XA9. It has been awarded $306,909 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

WFYSHK4214C8

CAGE Code

73XA9

Entity Structure

Partnership or Limited Liability Partnership

Established

N/A

Business Classifications

For Profit OrganizationLimited Liability Company

NAICS Codes

325180Other Basic Inorganic Chemical Manufacturing
325412Pharmaceutical Preparation Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

WEST COAST NUCLEAR PHARMACY, LLC specializes in the compounding, quality control, and distribution of radiopharmaceuticals for diagnostic and therapeutic medical applications. Leveraging expertise in nuclear pharmacy practices, the company ensures compliance with USP <825> and NRC regulations, deliv...

WEST COAST NUCLEAR PHARMACY, LLC specializes in the compounding, quality control, and distribution of radiopharmaceuticals for diagnostic and therapeutic medical applications. Leveraging expertise in nuclear pharmacy practices, the company ensures compliance with USP <825> and NRC regulations, delivering sterile, radiolabeled agents such as technetium-99m-based kits, fluorodeoxyglucose (FDG), and other positron emission tomography (PET) tracers under strict aseptic conditions. Their technical capabilities include radiopharmaceutical formulation, radionuclide handling, dose calibration, and transportation logistics compliant with DOT and NRC transport requirements. The company’s differentiation lies in its precision in radiolabeling chemistry, real-time quality assurance protocols, and just-in-time delivery models critical for time-sensitive nuclear medicine procedures. Award history does not provide sufficient detail to identify specific federal agencies or recurring contract patterns, and no recent awards are available for review. Consequently, no definitive agency relationships or mission-specific work profiles can be confirmed. The primary NAICS code 325412 reflects manufacturing of radiopharmaceuticals and other pharmaceutical preparations for nuclear medicine. In practice, this means the company operates as a specialized pharmaceutical manufacturer serving hospitals, imaging centers, and clinical research facilities requiring certified, on-demand radiopharmaceuticals. The business is positioned within the nuclear medicine supply chain, focusing on small-batch, high-purity production rather than mass-market pharmaceuticals. WEST COAST NUCLEAR PHARMACY, LLC is a small business structured as a limited liability company headquartered in Tampa, Florida. The firm holds no federal certifications such as 8(a), HUBZone, or WOSB. Its operational footprint is localized to the Southeastern U.S., with services likely supporting regional healthcare networks dependent on nuclear pharmacy supply chains. The company’s market positioning is that of a niche, technically rigorous provider in the radiopharmaceutical manufacturing sector.

Key Performance Metrics

Awards Count

26

All time

Active

0

Currently performing

Completed

26

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with WEST COAST NUCLEAR PHARMACY, LLC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for WEST COAST NUCLEAR PHARMACY, LLC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in WEST COAST NUCLEAR PHARMACY, LLC's top NAICS codes and agencies

NAICS: 561990
New
Federal
Intent to Sole Source Fire Suppression and Emergency Response Service
Solicitation # 36C26326Q0635_1
The Department of Veterans Affairs, Network Contracting Office 23, intends to award a sole source contract to the City of Minneapolis for fire suppression and emergency response services at the Veterans Affairs Medical Center in Minneapolis, Minnesota, including buildings at Fort Snelling. This action is being taken under the authority of FAR 6.103-1 and FAR 12.102(a), as the government has determined that only one responsible source can satisfy the agency requirements. The contractor is required to provide 24/7 contractor owned and contractor operated services, including responses to fire alarms, hazardous material spills, confined space rescues, and elevator entrapments. Key performance requirements include maintaining a minimum of four certified professional firefighters and two fire pumper apparatus with at least 1200 gpm capacity, ensuring a maximum response time of eight minutes to any location on the campus. The contractor must adhere to NFPA, IFC, OSHA, and State of Minnesota standards, maintain a minimum ISO rating of 3, and hold mutual aid agreements with at least two other municipal fire departments. Deliverables include annual building inspections, a phase-in plan due within ten days of award, and a confined space rescue plan due within fourteen days of the notice of award. Interested parties wishing to challenge the sole source determination must submit a capabilities statement by October 23, 2026.
Department Of Veterans Affairs

POSTED

about 22 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANS
Solicitation # SPE2DP-27-T-0111
Solicitation SPE2DP-27-T-0111 is a procurement request by the Defense Logistics Agency for five one-gallon bottles of USP Povidone-Iodine Cleansing Solution with a 7.5% active ingredient for external use. The product, identified by NSN 6505009947224, must have a total shelf life of 36 months, with at least 31 months remaining upon delivery to the first government activity. Storage requirements specify a temperature of 25 degrees Fahrenheit, with permitted excursions between 15 and 30 degrees Celsius. The items are to be delivered FOB Destination to the USS PRINCETON CG 59 with a required delivery date of October 16, 2026, and a delivery window of five days after receipt of order. The contract mandates strict adherence to medical marking and packaging standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial and capable of protecting contents from damage, with palletization following DLA requirement RP001. Because the material may be hazardous, suppliers must comply with OSHA Hazard Communication Standards, providing Safety Data Sheets and HCS labels for review prior to award. Administrative requirements include the use of Wide Area WorkFlow for invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, basic safeguarding of contractor information systems, and domestic sourcing restrictions such as the Buy American Act and the Berry Amendment.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days
View Details